How to Use ISO 13485 Certificate for Australian Medical Device Registration?

Professional Answer

The ISO 13485 certificate serves as crucial evidence of a quality management system (QMS) compliant with international standards for Australian medical device registration under the Therapeutic Goods Administration (TGA). However, it cannot replace product registration. For Class IIa and above devices, a valid ISO 13485 certificate, including latest audit reports and scope confirmation, must be submitted as part of the technical file. The certificate must cover design and development, production, and final inspection. A local Australian sponsor is mandatory. While MDSAP certificates may supplement ISO 13485, TGA requires independent QMS assessment. Ensure the certificate is issued by a TGA-recognized certification body and remains valid throughout the registration process.

Scope and Core Issues

ISO 13485 certification is a foundational QMS requirement but does not directly grant TGA approval. It is primarily used to demonstrate QMS conformity for Class IIa, IIb, III, and active implantable devices. Class I non-measuring/non-sterile devices are typically exempt. Key considerations include verifying the certificate version (e.g., ISO 13485:2016) and ensuring its scope covers all critical processes. Australia does not automatically recognize ISO 13485 certificates under GHWP mutual recognition; they must be from TGA-recognized bodies or supplemented by MDSAP.

Registration Logic

• Class I (non-measuring, non-sterile): QMS certificate not required, though maintaining compliance is recommended.
• Class IIa and above, or Class I measuring/sterile: Valid ISO 13485 certificate and supporting documents are mandatory.
• MDSAP holders: TGA accepts MDSAP audit results for QMS but still requires a separate product registration application.
• CE technical file reuse: ISO 13485 certificate must align with the CE certification system and remain valid during Australian registration.

Required Documentation

• ISO 13485 certificate (English translation if needed) with number, certifying body, validity, scope, and standard version.
• Latest audit report (surveillance or recertification).
• Scope statement confirming product types, design and production locations.
• Conformity declaration linking QMS scope to product design and manufacturing.
• Outsourced process controls if applicable.
• Risk management file per ISO 14971.
• Clinical evaluation or performance report as applicable.
• Labels and instructions for use in English, meeting TGA requirements.
• Australian sponsor agreement and authorization letter.

Common Mistakes

• Submitting an expired certificate.
• Certificate scope not matching the product (e.g., lacking design coverage).
• Using a certifying body not recognized by TGA.
• Assuming the certificate exempts other registration requirements (e.g., technical files, clinical data).
• Failing to link the certificate to QMS descriptions in the technical file.
• Confusing MDSAP with ISO 13485; TGA may still require separate ISO 13485 evidence.
• Sponsor lacking control over certificate changes.

Preparation Checklist

• Determine product classification per TGA rules (Schedules 1-5).
• Obtain a valid ISO 13485 certificate from a TGA-recognized body.
• Prepare technical documentation including design, risk management, clinical evaluation.
• Appoint an Australian sponsor with clear responsibilities.
• Ensure labels and IFUs comply with TGA English requirements.
• Establish a post-market surveillance plan covering adverse events, recalls, and updates.
• If multi-market, consider harmonizing QMS via MDSAP to reduce redundancy.
• Engage the certifying body early to confirm certificate acceptance for TGA.

AIMEILI Regulatory Interpretation

A frequent misconception is that an ISO 13485 certificate alone suffices for TGA registration. In reality, it confirms QMS compliance but does not substitute for product safety and efficacy evidence. Early project focus should be on product classification and registration pathway rather than immediate certificate submission. CE technical files and MDSAP certificates are often highly reusable, but risk management reports and clinical evaluations require localization for Australian populations and clinical settings. Sponsor selection is critical, as they manage certificate control and legal responsibilities. For multi-country registrations, a unified ISO 13485 system with MDSAP certification streamlines audits across Australia, Canada, Brazil, Japan, and the US (partial), reducing rework. Allow sufficient review timelines: Class I ~6 months, Class IIa-IIb 12–18 months, Class III longer; certificate expiry during review may delay the process.

Frequently Asked Questions

Is a UKAS-accredited ISO 13485 certificate accepted by TGA?

Yes, provided the certificate is valid, issued by a UKAS-accredited body with ISO 13485 scope, and the English version is legible. Certificates from pre-Brexit EU notified bodies are also accepted if they clearly state ISO 13485:2016.

Do I still need an ISO 13485 certificate if I hold an MDSAP certificate?

TGA accepts an MDSAP certificate covering Australia and product scope as alternative QMS evidence. In such cases, the MDSAP certificate and audit report replace the ISO 13485 certificate, but product registration technical review remains unchanged.

What if the certificate expires during registration?

TGA typically allows a grace period (e.g., 60 days) to submit a renewed certificate. Failure may lead to application withdrawal or rejection. Initiate renewal well before expiry and promptly submit the updated certificate along with a continuity statement.